Furthermore, genetic knockout of RBMS1 or pharmacological inhibition of RBMS1 using nortriptyline were shown to ameliorate pathological cardiac hypertrophy and heart failure. This evidence concerns the gene RBMS1 and cardiac hypertrophy.